Shengni Hua
- Cancer Research top 5%
- MicroRNA in disease regulation 6
- Cancer, Hypoxia, and Metabolism 4
- Molecular Biology top 10%
- RNA modifications and cancer 10
- Epigenetics and DNA Methylation 3
- Cancer-related gene regulation 3
- Ubiquitin and proteasome pathways 2
- Oncology top 10%
- Cancer-related Molecular Pathways 2
-
- Ferroptosis and cancer prognosis 3
- Journals
- SHILAP Revista de lepidopterología (2 papers)PLoS ONE (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Shengni Hua
21 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Cancer Research 587
- Molecular Biology 829
- Oncology 253
- Hepatology 30
- Pulmonary and Respiratory Medicine 122
Countries citing papers authored by Shengni Hua
This map shows the geographic impact of Shengni Hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengni Hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengni Hua more than expected).
Fields of papers citing papers by Shengni Hua
This network shows the impact of papers produced by Shengni Hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengni Hua. The network helps show where Shengni Hua may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shengni Hua, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapybreakdown → | 2024 | 55 |
| 2 | 2023 | 22 | |
| 3 | 2020 | 11 | |
| 4 | 2020 | 31 | |
| 5 | 2020 | 9 | |
| 6 | 2020 | 28 | |
| 7 | 2019 | 13 | |
| 8 | 2019 | 72 | |
| 9 | 2018 | 97 | |
| 10 | 2018 | 69 | |
| 11 | 2016 | 58 | |
| 12 | 2015 | 211 | |
| 13 | [Effect of HMGB1 on proliferation of human nasopharyngeal carcinoma cell line C666-1 in vitro]. | 2015 | 3 |
| 14 | 2014 | 20 | |
| 15 | 2014 | 16 | |
| 16 | 2014 | 150 | |
| 17 | 2014 | 41 | |
| 18 | 2013 | 31 | |
| 19 | 2013 | 111 | |
| 20 | 2013 | 14 |
About Shengni Hua
Shengni Hua is a scholar working on Cancer Research, Molecular Biology and Geriatrics and Gerontology, having authored 22 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), MicroRNA in disease regulation (6 papers), Cancer, Hypoxia, and Metabolism (4 papers), Epigenetics and DNA Methylation (3 papers), Ferroptosis and cancer prognosis (3 papers), Cancer-related gene regulation (3 papers), Ubiquitin and proteasome pathways (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cancer Research (587 citations), Molecular Biology (829 citations) and Oncology (253 citations). Shengni Hua has collaborated with scholars based in China and United States. Frequent co-authors include Weiyi Fang, Dehua Wu, Chengdong Liu, Li Liu, Qiaofen Fu, Meixiao Zhan, Ligong Lu, Yiyu Chen, Yue Fan and Chuanhui Cao. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.